Haematology & Oncology
Haematology & Oncology
We are dedicated to providing comprehensive care for patients with blood disorders and cancers. Our department is staffed with experienced specialists and equipped to deliver best available treatments and personalised care.
1. Malignant Disorders
Our Malignant Disorders section focuses on diagnosing and treating various forms of blood cancers. This includes:
- Leukaemia: We offer advanced therapies for both acute and chronic leukaemia, utilising the latest research and clinical trials to provide the best outcomes for our patients. Our treatments include:
- Acute Lymphoblastic Leukaemia (ALL)
- Acute Myeloid Leukaemia (AML)
- Chronic Lymphocytic Leukaemia (CLL)
- Chronic Myeloid Leukaemia (CML)
- Lymphoma: Our lymphoma services include precise diagnostic tools and innovative treatment options for both Hodgkin and non-Hodgkin lymphomas. Specific types treated include:
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Burkitt Lymphoma
- Myelomas: We specialise in the treatment of multiple myeloma and related disorders, offering comprehensive care plans that include chemotherapy and immunotherapy. Conditions treated include:
- Multiple Myeloma
- Plasmacytoma
- Amyloidosis
2. Benign Disorders (Inherited & Acquired)
We manage a wide range of non-cancerous blood disorders, including:
- Inherited Disorders: Conditions such as hereditary spherocytosis, thalassemia, and congenital dyserythropoietic anaemia are treated to ensure optimal care. Specific disorders include:
- Hereditary Spherocytosis
- Thalassemia (Alpha and Beta)
- Congenital Dyserythropoietic Anaemia
- G6PD Deficiency
- Acquired Disorders: Our team is experienced in handling acquired blood disorders like aplastic anaemia and immune thrombocytopenic purpura, providing effective and individualised treatment plans. Conditions treated include:
- Aplastic Anaemia
- Fanconis Anaemia
- Immune Thrombocytopenic Purpura (ITP)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Autoimmune Hemolytic Anaemia
- Inherited Disorders: Conditions such as hereditary spherocytosis, thalassemia, and congenital dyserythropoietic anaemia are treated to ensure optimal care. Specific disorders include:
3. Solid Tumours
Our Solid Tumours division addresses cancers that affect organs and tissues other than blood. This includes:
- Breast Cancer: Comprehensive care including surgery, chemotherapy, radiation therapy, and targeted therapies.
- Lung Cancer: Offering advanced treatments such as immunotherapy and precision medicine.
- Colorectal Cancer: Multidisciplinary approach including surgical interventions, chemotherapy, and radiotherapy.
- Prostate Cancer: Providing a range of treatments from active surveillance to advanced hormone therapy and radiation.
- Other Solid Tumours: Including gastric, pancreatic, liver, and ovarian cancers with tailored treatment plans.
4. Haemoglobinopathies
Specialising in disorders affecting haemoglobin, our team treats conditions such as:
- Sickle Cell Disease: Comprehensive management including pain management, blood transfusions, and potential curative therapies like bone marrow transplantation.
- Haemoglobin C and E Diseases: Managing complications with appropriate medical interventions and monitoring.
5. Myeloproliferative Neoplasms
Our services for Myeloproliferative Neoplasms (MPNs) include diagnosis and treatment of:
- Polycythemia Vera: Managing with phlebotomy, low-dose aspirin, and cytoreductive therapies.
- Essential Thrombocythemia: Utilising therapies to reduce platelet count and prevent complications.
- Primary Myelofibrosis: Offering treatments such as JAK inhibitors.
6. Bone Marrow Failure Disorders
We offer specialised care for patients with bone marrow failure disorders, such as:
- Myelodysplastic Syndromes (MDS): Providing supportive care, chemotherapy, and potential curative options like bone marrow transplantation.
- Shwachman-Diamond Syndrome: Comprehensive care involving hematologic and supportive therapies.
7. Haemostasis & Coagulation Disorders
Our Haemostasis & Coagulation unit addresses bleeding and clotting disorders, including:
- Haemophilia: Providing factor replacement therapy and prophylactic treatments.
- Von Willebrand Disease: Managing with desmopressin and factor replacement therapies.
- Acquired Coagulation Disorders: Treating conditions like disseminated intravascular coagulation (DIC) and vitamin K deficiency with appropriate medical interventions.
- Thrombophilia: Addressing genetic and acquired thrombophilic conditions with anticoagulation therapy and monitoring.
At NIBD, we are committed to advancing the field of haematology and oncology through innovative treatments, compassionate care, and ongoing research to improve patient outcomes.